Risk factors for Cryptococcus gattii infection, British Columbia, Canada

Emerging Infectious Diseases

Volumn 17, Issue 2, 2011, Pages 193-199

  MacDougall, Laura ^a   Fyfe, Murray ^a,b,c   Romney, Marc ^a,c,d   Starr, Mike ^a,e   Galanis, Eleni ^a,c  

^a BRITISH COLUMBIA CENTRE FOR DISEASE CONTROL   (Canada)

^b VANCOUVER ISLAND HEALTH AUTHORITY   (Canada)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^d ST PAUL S HOSPITAL   (Canada)

^e ROYAL CHILDREN'S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

METHYLPREDNISOLONE; PREDNISONE; STEROID;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BEHAVIOR; CANADA; CANCER INVASION; CASE CONTROL STUDY; CLINICAL ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; CRYPTOCOCCOSIS; CRYPTOCOCCUS GATTII; ENVIRONMENTAL FACTOR; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; LUNG DISEASE; MALE; PNEUMONIA; RISK ASSESSMENT; RISK FACTOR; SMOKING;

AGED; AGED, 80 AND OVER; BRITISH COLUMBIA; CASE-CONTROL STUDIES; CRYPTOCOCCOSIS; CRYPTOCOCCUS GATTII; FEMALE; HUMANS; IMMUNOCOMPROMISED HOST; INTERVIEWS AS TOPIC; MALE; MIDDLE AGED; NEOPLASMS; QUESTIONNAIRES; RISK FACTORS; SMOKING;

EID: 79551625332     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid1702.101020     Document Type: Article

References (39)

1. Galanis E, MacDougall L. Epidemiology of Cryptococcocus gattii, British Columbia, Canada, 1999-2007. Emerg Infect Dis. 2010;16:251-7.
2. Fyfe M, MacDougall L, Romney M, Starr M, Pearce M, Mak S, et al. Cryptococcus gattii infections on Vancouver Island, British Columbia, Canada: emergence of a tropical fungus in a temperate environment. Can Commun Dis Rep. 2008;34:1-12.
3. Ellis DH, Pfeiffer TJ. Natural habitat of Cryptococcus neoformans var. gattii. J Clin Microbiol. 1990;28:1642-4.
4. Kidd SE, Chow Y, Mak S, Bach PJ, Chen H, Hingston AO, et al. Characterization of environmental sources of the human and animal pathogen Cryptococcus gattii in British Columbia, Canada, and the Pacific Northwest of the United States. Appl Environ Microbiol. 2007;73:1433-43. DOI: 10.1128/AEM.01330-06
5. Bartlett KH, Kidd SE, Kronstad JW. The emergence of Cryptococcus gattii in British Columbia and the Pacific Northwest. Curr Infect Dis Rep. 2008;10:58-65. DOI: 10.1007/s11908-008-0011-1
6. Sarosi GA, Silberfarb PM, Tosh FE. Cutaneous cryptococcosis. A sentinel of disseminated disease. Arch Dermatol. 1971;104:1-3. DOI: 10.1001/archderm.104.1.1
7. Behrman RE, Masci JR, Nicholas P. Cryptococcal skeletal infections: case report and review. Rev Infect Dis. 1990;12:181-90.
8. Chen S, Sorrell T, Nimmo G, Speed B, Currie B, Ellis D, et al. Epidemiology and host and variety-dependent characteristics of infection due to Cryptococcus neoformans in Australia and New Zealand. Australasian Cryptococcal Study Group. Clin Infect Dis. 2000;31:499-508. DOI: 10.1086/313992
9. Sorrell TC. Cryptococcus neoformans variety gattii. Med Mycol. 2001;39:155-168.
10. Levine S, Zimmerman HM, Scorza A. Experimental cryptococcsis (turulosis). Am J Pathol. 1957;33:385-409.
11. Diamond RD, Bennett JE. Prognostic factors in cryptococcal meningitis. Ann Intern Med. 1974;80:176-81.
12. Duperval R, Hermans PE, Brewer NS, Roberts GD. Cryptococcus, with emphasis on the significance of isolation of Cryptococcus neoformans from the respiratory tract. Chest. 1977;72:13-9. DOI: 10.1378/chest.72.1.13
13. Dromer F, Mathoulin S, Dupont B, Laporte A. Epidemiology of cryptococcosis in France: a 9-year survey (1985-1993). French Cryptococcosis Study Group. Clin Infect Dis. 1996;23:82-90.
14. Casadevall A, Perfect JR. Cryptococcus neoformans. Washington: ASM Press; 1998. p. 357-63.
15. Mabee CL, Mabee SW, Kirkpatrick RB, Koletar SL. Cirrhosis: a risk factor for cryptococcal peritonitis. Am J Gastroenterol. 1995;90:2042-5.
16. Speed BR, Kaldor J. Rarity of cryptococcal infection in children. Pediatr Infect Dis J. 1997;16:536-7. DOI: 10.1097/00006454-199705000-00024
17. Olson PE, Earhart KC, Rossetti RJ, Newton JA, Wallace MR. Smoking and risk of cryptococcosis in patients with AIDS. JAMA. 1997;277:629-30. DOI: 10.1001/jama.277.8.629
18. Kwon-Chung KJ, Varma A. Do major species concepts support one, two, or more species within Cryptococcus neoformans? FEMS Yeast Res. 2006;6:574-87. DOI: 10.1111/j.1567-1364.2006.00088.x
19. MacDougall L, Kidd S, Galanis E, Mak S, Leslie MJ, Cieslak PR, et al. Spread of Cryptococcus gattii in British Columbia, Canada and its detection in the Pacific Northwest, USA. Emerg Infect Dis. 2007;13:42-50. DOI: 10.3201/eid1301.060827
20. Meyer W, Castaneda A, Jackson S, Huynh M, Castaneda E. Molecular typing of IberoAmerican Cryptococcus neoformans isolates. Emerg Infect Dis. 2003;9:189-95.
21. Kidd SE, Guo H, Bartlett KH, Xu J, Kronstad JW. Comparative gene genealogies indicate that two clonal lineages of Cryptococcus gattii in British Columbia resemble strains from other geographical areas. Eukaryot Cell. 2005;4:1629-38. DOI: 10.1128/EC.4.10.1629-1638.2005
22. BC STATS. Service BC, British Columbia Ministry of Labour and Citizens' Services. Population estimates (1986-2006) and projections (2007-2036) (PEOPLE 32) [cited Dec 8 2010]. http://www.bcstats.gov.bc.ca/data/pop/pop/dynamic/PopulationStatistics/SelectRegionType.asp?category=Health
23. Statistics Canada, Canadian Community Health Survey (CCHS 3.1), 2005. Canadian Socioeconomic Information Management System Table105-0427 [cited 2008 Apr 2]. http://cansim2.statcan.gc.ca/cgi-win/cnsmcgi.exe?Lang=Eng&Dir-Rep=CII/&RegTkt=&C2Sub=&CNSM-Fi=CII/CII_1-eng.htm
24. BC Cancer Agency. Prevalence. 2005 [cited 2008 Apr 9]. http://www.bccancer.bc.ca/HPI/CancerStatistics/FF/Prev.htm
25. Boulos D, Yan P, Schanzer D, Remis RS, Archibald CP. Estimates of HIV prevalence and incidence in Canada, 2005. Can Commun Dis Rep. 2006;32:165-74.
26. Speed B, Dunt D. Clinial and host differences between infections with the two varieties of Cryptococcus neoformans. Clin Infect Dis. 1995;21:28-34.
27. Goldman DL, Khine H, Abadi J, Lindenberg DJ, Pirofski LA, Niang R, et al. Serologic evidence for Cryptococcus neoformans infection in early childhood. Pediatrics. 2001;107:e66. DOI: 10.1542/ peds.107.5.e66
28. Bennington JL, Haber SL, Morgenstern NL. Increased susceptibility to cryptococcosis following steroid therapy. Dis Chest. 1964;45:262-3.
29. Baddley JW, Perfect JR, Oster RA, Pankey GA, Henderson H, Haas DW, et al. Pulmonary cryptococcosis in patients without HIV infection: factors associated with disseminated disease. Eur J Clin Microbiol Infect Dis. 2008;27:937-43.
30. Hedlund J, Kalin M, Ortqvist A. Recurrence of pneumonia in middleaged and elderly adults after hospital-treated pneumonia: aetiology and predisposing conditions. Scand J Infect Dis. 1997;29:387-92. DOI: 10.3109/00365549709011836
31. Geppert EF. Chronic and recurrent pneumonia. Semin Respir Infect. 1992;7:282-8.
32. Duperval R, Hermans PE, Brewer NS, Roberts GD. Cryptococcosis, with emphasis on the significance of isolation of Cryptococcus neoformans from the respiratory tract. Chest. 1977;72:13-9. DOI: 10.1378/chest.72.1.13
33. Seaton RA, Wembri JP, Armstrong P, Ombiga J, Maraqi S, Kevau I. Symptomatic human immunodeficiency virus (HIV) infection in Papua New Guinea. Aust N Z J Med. 1996;26:783-8. DOI: 10.1111/ j.1445-5994.1996.tb00625.x
34. Chaturvedi S, Dyavaiah M, Larsen RA, Chaturvedi V. Cryptococcus gattii in AIDS patients, southern California. Emerg Infect Dis. 2005;11:1686-92.
35. Kidd SE, Bach PJ, Hingston AO, Mak S, Chow Y, MacDougall L, et al. Cryptococcus gattii dispersal mechanisms, British Columbia, Canada. Emerg Infect Dis. 2007;13:51-7. DOI: 10.3201/ eid1301.060823
36. Arcavi L, Benowitz NL. Cigarette smoking and infection. Arch Intern Med. 2004;164:2206-16. DOI: 10.1001/archinte.164.20.2206
37. Kidd SE, Chow Y, Mak S, Bach PJ, Chen H, Hingston AO, et al. Characterization of environmental sources of the human and animal pathogen Cryptococcus gattii in British Columbia, Canada, and the Pacific Northwest of the United States. Appl Environ Microbiol. 2007;73:1433-43. DOI: 10.1128/AEM.01330-06
38. MacDougall L, Fyfe M. Emergence of Cryptococcus gattii in a novel environment provides clues to its incubation period. J Clin Microbiol. 2006;44:1851-2. DOI: 10.1128/JCM.44.5.1851-1852.2006
39. Datta K, Bartlett KH, Baer R, Byrnes E, Galanis E, Heitman J, et al. Spread of Cryptococcus gattii into Pacific Northwest region of the United States. Emerg Infect Dis [cited 2009 Aug 1]. http://www.cdc.gov/EID/content/15/8/1185.htm